- Home
- OESX vs JUNS Comparison
OESX vs JUNS Comparison
Compare OESX & JUNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OESX
- JUNS
- Stock Information
- Founded
- OESX 1996
- JUNS 2015
- Country
- OESX United States
- JUNS United States
- Employees
- OESX N/A
- JUNS N/A
- Industry
- OESX Building Products
- JUNS
- Sector
- OESX Consumer Discretionary
- JUNS
- Exchange
- OESX Nasdaq
- JUNS NYSE
- Market Cap
- OESX 19.3M
- JUNS 20.5M
- IPO Year
- OESX 2007
- JUNS 2024
- Fundamental
- Price
- OESX $0.60
- JUNS $1.01
- Analyst Decision
- OESX Strong Buy
- JUNS
- Analyst Count
- OESX 2
- JUNS 0
- Target Price
- OESX $1.75
- JUNS N/A
- AVG Volume (30 Days)
- OESX 135.4K
- JUNS 706.3K
- Earning Date
- OESX 06-26-2025
- JUNS 08-11-2025
- Dividend Yield
- OESX N/A
- JUNS N/A
- EPS Growth
- OESX N/A
- JUNS N/A
- EPS
- OESX N/A
- JUNS N/A
- Revenue
- OESX $79,720,000.00
- JUNS N/A
- Revenue This Year
- OESX $19.97
- JUNS N/A
- Revenue Next Year
- OESX $16.45
- JUNS N/A
- P/E Ratio
- OESX N/A
- JUNS N/A
- Revenue Growth
- OESX N/A
- JUNS N/A
- 52 Week Low
- OESX $0.56
- JUNS $0.51
- 52 Week High
- OESX $1.12
- JUNS $19.51
- Technical
- Relative Strength Index (RSI)
- OESX 45.72
- JUNS N/A
- Support Level
- OESX $0.59
- JUNS N/A
- Resistance Level
- OESX $0.61
- JUNS N/A
- Average True Range (ATR)
- OESX 0.04
- JUNS 0.00
- MACD
- OESX 0.01
- JUNS 0.00
- Stochastic Oscillator
- OESX 31.54
- JUNS 0.00
About OESX Orion Energy Systems Inc.
Orion Energy Systems Inc is a developer, manufacturer, and seller of lighting and energy management systems. The company segments include Orion Lighting Segment, Orion Maintenance Segment and Orion Electric Vehicle Charging Segment. It derives maximum revenue from Lighting Segment.
About JUNS JUPITER NEUROSCIENCES INC
Jupiter Neurosciences Inc is a clinical-stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a resveratrol platform product that targets the treatment of neuro-inflammation. Its platform product, JOTROL, offers potential therapeutic benefit to the majority of central nervous system diseases such as Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases.